REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -7.7% | 17,500 | 0.0% | 0.00% | – |
| Q2 2023 | $26 | +85.7% | 17,500 | 0.0% | 0.00% | – |
| Q1 2023 | $14 | -39.1% | 17,500 | 0.0% | 0.00% | – |
| Q4 2022 | $23 | -100.0% | 17,500 | -47.8% | 0.00% | – |
| Q3 2022 | $56,000 | +24.4% | 33,500 | +52.3% | 0.00% | – |
| Q2 2022 | $45,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,111,049 | $1,522,137 | 0.47% |
| Sarissa Capital Management LP | 185,183 | $253,701 | 0.03% |
| FEDERATED HERMES, INC. | 3,875,578 | $5,348,298 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 40,260 | $55,156 | 0.00% |
| Virtu Financial LLC | 25,921 | $36 | 0.00% |
| GRIMES & COMPANY, INC. | 10,547 | $14,449 | 0.00% |
| ROYAL BANK OF CANADA | 80 | $0 | 0.00% |
| VANGUARD GROUP INC | 285,050 | $390,519 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 233,207 | $321,826 | 0.00% |
| UBS Group AG | 408 | $558 | 0.00% |